Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | Lanciego, J.L. (José Luis) | - |
| dc.contributor.advisor | González-Aseguinolaza, G. (Gloria) | - |
| dc.creator | Sucunza, D. (Diego) | - |
| dc.date.accessioned | 2021-07-06T11:42:46Z | - |
| dc.date.available | 2021-07-06T11:42:46Z | - |
| dc.date.issued | 2021-07-06 | - |
| dc.date.submitted | 2019-10-07 | - |
| dc.identifier.citation | SUCUNZA GUIBERT, Diego. “Glucocerebrosidase gene therapy in animal models of Parkinson Disease". Lanciego, J. L. y González, G. (dirs.). Tesis doctoral. Universidad de Navarra, Pamplona, 2019. | es_ES |
| dc.identifier.uri | https://hdl.handle.net/10171/61068 | - |
| dc.description.abstract | Parkinson´s Disease (PD) is the first most common movement disorder and second most common neurodegenerative disease that affects 1.5% of the global population above 65 years old. Although the incidence of PD varies depending on genetic, race/ethnicity and environmental factors, advanced age has been appointed as the main risk factor for PD. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Universidad de Navarra | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.subject | Parkinson disease | es_ES |
| dc.subject | Enfermedad de parkinson | es_ES |
| dc.subject | Materias Investigacion::Ciencias de la Salud | es_ES |
| dc.title | Glucocerebrosidase gene therapy in animal models of Parkinson Disease | es_ES |
| dc.type | info:eu-repo/semantics/doctoralThesis | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
